Product Information

TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Bausch & Lomb Incorporated, priced at $5.1316 per ML under NDC 24208029525. Its NADAC has been published 657 times since Nov 28, 2013.

TOBRAMYCIN-DEXAMETH OPHTH SUSP

Tobramycin and Dexamethasone
$5.1316per ML

Strength

1; 3 mg/mL; mg/mL

NDC

24208029525

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Last Updated

6/17/2026

Active Ingredients

DEXAMETHASONE; TOBRAMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA064134

On Market Since

10/27/1999

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.

Current price$5.1316 per ML
All-time high$18.1894 (Jan 15, 2014)
All-time low$4.4089 (Dec 17, 2025)
52-week high$6.6531
52-week low$4.4089
Median price$14.8752
Average price$12.9001
Largest weekly change-44.9% (Jul 17, 2024)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.5%

3M

+4.3%

6M

+16.4%

1Y

-18.2%

3Y

-29.0%

5Y

-69.4%

All

-70.4%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Bausch & Lomb Incorporated, is $5.1316 per ML (NDC 24208029525), effective Jun 24, 2026.

How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 70.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?

Since Nov 28, 2013, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $4.4089 (Dec 17, 2025) to a high of $18.1894 (Jan 15, 2014), with a median of $14.8752 per ML.

Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOBRAMYCIN-DEXAMETH OPHTH SUSP, is $4.2803 per ML — about 17% below TOBRAMYCIN-DEXAMETH OPHTH SUSP.

Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?

TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 24208029525) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.